AndreaBozzo/ceres-open-data-index huggingface dataset:
Health Professional Shortage Areas - Primary Care

[<a href='https://files.hawaii.gov/dbedt/op/gis/data/hpsa.pdf' target='_blank' rel='nofollow ugc noopener noreferrer'>Metadata</a>] Primary Health Care Professional Shortage Areas as of April 2024. Source - Hawaii State Department of Health. Description: Designation of Health Professional Shortage Areas for Primary Care. See also Professional Health Shortage Areas for Dental Health and Mental Health. A Health Professional Shortage Area (HPSA) means any of the following which has a shortage of health professionals: (a) an urban or rural area which is a rational service area for the delivery of health services, (b) a population group, or (c) a public or nonprofit private medical facility. HPSAs are divided into three major categories according to the type of health professional shortage: primary care, dental or mental health HPSAs. For more information about HPSA’s, visit the Hawaii State Department of Health HPSA website at<a href='https://health.hawaii.gov/opcrh/home/health-professional-shortage-area-hpsa/' target='_blank' rel='nofollow ugc noopener noreferrer'> https://health.hawaii.gov/opcrh/home/health-professional-shortage-area-hpsa/</a>. Hawaii Statewide GIS Program staff downloaded data from <a href='https://data.hrsa.gov/data/download?hmpgtitle=hmpg-hrsa-data' target='_blank' rel='nofollow ugc noopener noreferrer'>https://data.hrsa.gov/data/download?hmpgtitle=hmpg-hrsa-data</a> April 2024. Projected to UTM Zone 4 NAD 83 HARN, and clipped to coastline. For additional information, please refer to summary metadata at <a href='https://files.hawaii.gov/dbedt/op/gis/data/hpsa.pdf' target='_blank' rel='nofollow ugc noopener noreferrer'>https://files.hawaii.gov/dbedt/op/gis/data/hpsa.pdf</a> or contact Hawaii Statewide GIS Program, Office of Planning and Sustainable Development, State of Hawaii; PO Box 2359, Honolulu, Hi. 96804; (808) 587-2846; email: <a href='mailto:gis@hawaii.gov' target='_blank' rel='nofollow ugc noopener noreferrer'>gis@hawaii.gov</a>; Website: <a href='https://planning.hawaii.gov/gis' target='_blank' rel='nofollow ugc noopener noreferrer'>https://planning.hawaii.gov/gis</a>.
Diligent Recruitment — Intelligent Recruitment

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 530719: o-Anisic acid, tridec-2-ynyl ester

Chemical compound data from PubChem database. IUPAC Name: tridec-2-ynyl 2-methoxybenzoate. Molecular Formula: C21H30O3. Molecular Weight: 330.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E40113-T1: [Translated] PYROGLUTAMIC ACID DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE,INTERMEDIATE PRODUCTS AND FUNCIDAL AND/OR BACTERICIDE AGENTS, AND COSMETIC OR PHARMACEUTICAL AGENTS.

1. Claims for the Contracting States : BE CH DE GB IT LI LU NL SE Pyroglutamic derivative, characterized in that it corresponds to the following formula (I) :  see diagramm : EP0135444,P15,F2  in which : Y and Z have the following meanings : Y : -CO CH2 Cl  see diagramm : EP0135444,P15,F3   see diagramm : EP0135444,P15,F4  Z : -COO CH3 ; Y : -CO CH2 Cl Z : -COO CH3 ;  see diagramm : EP0135444,P15,F5  Z : -COO CH3 ;  see diagramm : EP0135444,P15,F6  Z : -COO CH3 ;  see diagramm : EP0135444,P15,F7  Z : -COO CH3 ;  see diagramm : EP0135444,P16,F1  Z : -COOH ; Y : -COCH2 -Cl   Z : -COOH 1. Claims for the Contracting State : AT Process for preparing a pyroglutamic derivative of the following formula (I) :  see diagramm : EP0135444,P17,F2  in which : Y and Z have the following meanings : Y : -CO CH2 Cl  see diagramm : EP0135444,P17,F3   see diagramm : EP0135444,P17,F4  Z : -COO CH3 ; Y : -CO CH2 Cl Z : -COO CH3 ;  see diagramm : EP0135444,P17,F5  Z : -COO CH3 ;  see diagramm : EP0135444,P17,F6  Z : -COO CH3 ;  see diagramm : EP0135444,P17,F7  Z : -COO CH3 ;  see diagramm : EP0135444,P17,F8  Z : -COOH ; Y : -COCH2 -Cl    Z : -COOH characterized in that a compound of the following formula (II) :  see diagramm : EP0135444,P17,F9  in which W is chosen from an ester group corresponding to Z defined above, or -COOSiMe3 group ; is reacted with an acylating agent such as an organic halide of formula Y-Hal, where Hal = halogen, especially chlorine, and where Y is defined as above, or with diketene ; and, in the case where W is a -COOSiMe3 group, the resulting intermediate product is converted to the corresponding acid or ester, for example by a hydrolysis or alcoholysis of this product.
2013 CMHS Uniform Reporting System (URS) Table for Montana

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Montana for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Patent AT-E401127-T1: [Translated] BREAKER

A crusher comprises a main shaft a portion of which is disposed in a bore of a rotatable eccentric shaft, the main shaft (1) having a central axis that is inclined with respect to the axis of rotation of the eccentric shaft, and a first crushing head attached to the main shaft and rotatable by the main shaft with respect to a second crushing head so that constrained stroke motion is effected between the first crushing head and the second crushing head. The inclination of the central axis of the main shaft is changed with respect to the axis of rotation of the eccentric shaft by a gear transmission comprising cog wheels, such that the magnitude of the constrained stroke motion changes.
Assessment of performance of four mortality prediction systems in a Saudi Arabian intensive care unit

Introduction
          The purpose of this study is to assess the performance of Acute Physiology and Chronic Health Evaluation (APACHE) II, Simplified Acute Physiology Score (SAPS) II, Mortality Probability Model MPM II0 and MPM II24 systems in a major tertiary care hospital in Riyadh, Saudi Arabia.
        
        
          Methods
          The following data were collected prospectively on all consecutive patients admitted to the Intensive Care Unit between 1 March 1999 and 31 December 2000: demographics, APACHE II and SAPS II scores, MPM variables, ICU and hospital outcome. Predicted mortality was calculated using original regression formulas. Standardized mortality ratio (SMR) was computed with 95% confidence intervals (CI). Calibration was assessed by calculating Lemeshow–Hosmer goodness-of-fit C statistics. Discrimination was evaluated by calculating the Area Under the Receiver Operating Characteristic Curves (ROC AUC).
        
        
          Results
          Predicted mortality by all systems was not significantly different from actual mortality [SMR for MPM II0: 1.00 (0.91–1.10), APACHE II: 1.00 (0.8–1.11), SAPS II: 1.09 (0.97–1.21), MPM II24 0.92 (0.82–1.03)]. Calibration was best for MPM II24 (C-statistic: 14.71, P = 0.06). Discrimination was best for MPM II0 (ROC AUC:0.85) followed by MPM II24 (0.84), APACHE II (0.83) then SAPS II (0.79).
        
        
          Conclusions
          In our ICU population: 1) Overall mortality prediction, estimated by standardized mortality ratio, was accurate, especially for MPM II0 and APACHE II. 2) MPM II24 has the best calibration. 3) SAPS II has the lowest calibration and discrimination. The local performance of MPM II24 in addition to its ease-to-use makes it an attractive model for mortality prediction in Saudi Arabia.
The velocity of ultrasound in human primary melanoma tissue - implications for the clinical use of high resolution sonography

Background
          Ultrasonography with 20 MHz frequency can be used to estimate tumour thickness preoperatively in malignant melanoma (MM) of the skin. The vertical invasion depth is the single most important prognostic factor for localised MM, and its preoperative knowledge would be very useful for the planning of surgical procedures. Since ultrasonographic distance measurements directly depend upon the tissue specific ultrasound velocity, we determined the ultrasound velocity in primary melanoma.
        
        
          Results
          Ultrasound velocity was calculated from runtime differences of a 20 MHz ultrasound signal along a known distance either through water alone or through thick specimens of primary MM. The ultrasound velocities varied between 1553 m/s and 1588 m/s with a mean of 1564 m/s in four different MM specimens. The analysis of different parts of the specimens showed that the variation of the calculated velocities was larger between different specimens than within one individual specimen.
        
        
          Conclusions
          The ultrasound velocity in MM tissue may be slightly lower than normally assumed, thereby explaining a part of the overestimation usually found in sonographic measurement of melanoma invasion depth. Additionally, the variation of ultrasound velocity between individual tumours may contribute to the impairment of the correlation found between sonometry and Breslow's measurement of MM invasion depth. For practical reasons, a setting of 1580 m/s will be appropriate for ultrasonography of primary malignant melanoma.
2010 National Survey of Substance Abuse Treatment Services (N-SSATS) Census Regional Report

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) Census regional report that focuses on the rate of clients in treatment for substance abuse in 2010. There are 9 U.S. Census  regional  divisions. The National Survey of Substance Abuse Treatment Services (N-SSATS) is an annual census of facilities in the United States, both public and private, that provide substance abuse treatment.
HHS System of Records Notices (SORNs) Metadata Inventory

The U.S. Department of Health and Human Services (HHS) publishes the HHS System of Records Notices (SORNs) Metadata Inventory to provide machine-readable access to over 200 publicly available HHS SORNs. These notices inform the public about records HHS maintains on individuals, as required by the Privacy Act and federal law. The inventory is available via open API and downloadable Excel or CSV formats.

Visit the official HHS SORN homepage: <a href="https://www.hhs.gov/foia/privacy/sorns/index.html">https://www.hhs.gov/foia/privacy/sorns/index.html</a>.
Compound 528976: 1,2-Hentriacontanediol, di-TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl(1-trimethylsilyloxyhentriacontan-2-yloxy)silane. Molecular Formula: C37H80O2Si2. Molecular Weight: 613.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526361: 4,6-Dibromo-1,2,8,9-tetrachloro-dibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 4,6-dibromo-1,2,8,9-tetrachlorodibenzo-p-dioxin. Molecular Formula: C12H2Br2Cl4O2. Molecular Weight: 479.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - Table II. Shiga toxin to Shigellosis

NNDSS - Table II. Shiga toxin to Shigellosis - 2016.  In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.
Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.   NP:  Nationally notifiable but not published.   Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum.
 
* Case counts for reporting year 2016 are provisional and subject to change.   For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.   Data for TB are displayed in Table IV, which appears quarterly.  
† Three low incidence conditions, rubella, rubella congenital, and tetanus, have been moved to Table II to facilitate case count verification with reporting jurisdictions.
§ Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin-positive, not serogrouped.
Compound 528331: Isobutyl furfuryl sulfide

Chemical compound data from PubChem database. IUPAC Name: 1-(3-methylbutylsulfanylmethyl)cyclopenta-1,3-diene. Molecular Formula: C11H18S. Molecular Weight: 182.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401659-T1: [Translated] KEYBOARD AND KEYBOARD ARRANGEMENT

A keypad includes a light guide panel, the interior of which light propagates through, a film positioned on the upper surface of the light guide panel and having at least one key button positioned on the upper surface thereof, and at least one reflective pattern fixedly positioned with respect to the light guide panel to reflect a part of the light, which propagates through the interior of the light guide panel, towards the key button.
Compound 528794: Cyclotetratriacontasiloxane, octahexacontamethyl

Chemical compound data from PubChem database. IUPAC Name: 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28,30,30,32,32,34,34,36,36,38,38,40,40,42,42,44,44,46,46,48,48,50,50,52,52,54,54,56,56,58,58,60,60,62,62,64,64,66,66,68,68-octahexacontamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45,47,49,51,53,55,57,59,61,63,65,67-tetratriacontaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28,30,32,34,36,38,40,42,44,46,48,50,52,54,56,58,60,62,64,66,68-tetratriacontasilacyclooctahexacontane. Molecular Formula: C68H204O34Si34. Molecular Weight: 2521.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527242: Tricyclovetivenol

Chemical compound data from PubChem database. IUPAC Name: (7,7-dimethyl-6-methylidene-2-tricyclo[6.2.1.01,5]undecanyl)methanol. Molecular Formula: C15H24O. Molecular Weight: 220.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Minneapolis: Drug-Related Emergency Department Visits, 2004-2011 - Illicits (excluding alcohol)

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving illicit drugs for the Minneapolis metropolitan area, covering 2004-2011. These visits involve the use of drugs that have limited or no therapeutic value and are generally illegal if taken without a prescription. It also includes visits involving the inhalation of substances for their psychoactive properties (e.g., sniffing model airplane glue).
Model-supported estimation of mortality rates in Baltic cod (

Background
          Changes in the survival-rate during the larval phase may strongly influence the recruitment level in marine fish species. During the larval phase different 'critical periods' are discussed, e.g. the hatching period and the first-feeding period. No such information was available for the Baltic cod stock, a commercially important stock showing reproduction failure during the last years. We calculated field-based mortality rates for larval Baltic cod during these phases using basin-wide abundance estimates from two consecutive surveys. Survey information was corrected by three dimensional hydrodynamic model runs.
        
        
          Results
          The corrections applied for transport were of variable impact, depending on the prevailing circulation patterns. Especially at high wind forcing scenarios, abundance estimates have the potential to be biased without accounting for transport processes. In May 1988 mortality between hatch and first feeding amounted to approximately 20% per day. Mortality rates during the onset of feeding were considerably lower with only 7% per day. In August 1991 the situation was vice versa: Extremely low mortality rates of 0.08% per day were calculated between hatch and first feeding, while the period between the onset of feeding to the state of an established feeder was more critical with mortality rates of 22% per day.
        
        
          Conclusions
          Mortality rates during the different proposed 'critical periods' were found to be highly variable. Survival rates of Baltic cod are not only influenced by a single 'critical period', but can be limited at different points during the larval phase, depending on several biotic and abiotic factors.
Compound 527080: 6,10,14-Trimethyl-tetratriacontane

Chemical compound data from PubChem database. IUPAC Name: 6,10,14-trimethyltetratriacontane. Molecular Formula: C37H76. Molecular Weight: 521.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528055: tert-Butyl(dimethyl)silyl 2-([tert-butyl(dimethyl)silyl]amino)propanoate

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] 2-[[tert-butyl(dimethyl)silyl]amino]propanoate. Molecular Formula: C15H35NO2Si2. Molecular Weight: 317.61. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Managed Care Institutional Provider Network Data: June 30, 2014

The primary purpose for the Provider Network Data System (PNDS) is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans. This dataset reflects institutional provider data. Provider Network Data System information is self reported. For more information, go to http://www.health.ny.gov/health_care/managed_care/.
Hydrocodone bitartrate and homatropine methylbromide

Hydromet is a prescription oral syrup containing hydrocodone bitartrate (an opioid pain reliever and cough suppressant) and homatropine methylbromide (an anticholinergic). It's used to relieve cough symptoms. As a Schedule II controlled substance, it requires a doctor's supervision. Manufactured by Actavis Pharma, Inc. This information was generated using AI and is provided for informational and research purposes only.
Compound 527151: 2,2,2-Trichloroethyl propionate

Chemical compound data from PubChem database. IUPAC Name: 2,2,2-trichloroethyl propanoate. Molecular Formula: C5H7Cl3O2. Molecular Weight: 205.46. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
New York 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.
Hospital Inpatient Discharges (SPARCS De-Identified): Patient Safety Indicators (PSI) Area Measures by Patient County: Calendar Year 2015

The datasets contain hospital discharges counts (numerators, denominators, volume counts), observed, expected and risk-adjusted rates with corresponding 95% confidence intervals for Patient Safety Indicators generated using methodology developed by Agency for Healthcare Research and Quality (AHRQ).

The PSIs are a set of indicators providing information on potential in hospital complications and adverse events following surgeries, procedures, and childbirth. The PSIs were developed by AHRQ after a comprehensive literature review, analysis of ICD-9-CM codes, review by a clinician panel, implementation of risk adjustment, and empirical analyses.

All PSI measures were calculated using Statewide Planning and Research Cooperative System (SPARCS) inpatient data beginning 2009. US Census data files provided by AHRQ were used to derive denominators for county level (area level) PSI measures.

The mortality, volume and utilization measures PSIs are presented by hospital as rates or counts. Area-level measures are presented by county as rates.
Information Memorandum (IM-04-02)

This Information Memorandum (IM) provides information on Fiscal Year (FY) 2003 Reallocated Funds under the Education and Training Vouchers (ETV) program of the Chafee Foster Care Independence Program (CFCIP) under the Foster Care Independence Act of 1999.

Metadata-only record linking to the original dataset. Open original dataset below.